The rarity of various forms of vasculitis, as well as other rheumatic diseases, presents difficulties in studying the genetics of these diseases as well as for evaluating treatments. Might new approaches, such as joint genetic analyses and drug repurposing, provide opportunities to learn more about these diseases and identify new therapies and serve as a basis for basket clinical trials?
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
New clinical trial design in precision medicine: discovery, development and direction
Signal Transduction and Targeted Therapy Open Access 04 March 2024
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Lengline, E. et al. Basket clinical trial design for targeted therapies for cancer: a French National Authority for Health statement for health technology assessment. Lancet Oncol. 22, e430–e434 (2021).
Ortiz-Fernandez, L. et al. Identification of new risk loci shared across systemic vasculitides points towards potential target genes for drug repurposing. Ann. Rheum. Dis. (2023).
Lin, V. S., Xu, Z. F., Huang, D. C. S. & Thijssen, R. BH3 mimetics for the treatment of B-cell malignancies-insights and lessons from the clinic. Cancers (Basel) 12, 3353 (2020).
Morrow, G. B. & Mutch, N. J. Past, present, and future perspectives of plasminogen activator inhibitor 1 (PAI-1). Semin. Thromb. Hemost. 49, 305–313 (2023).
Nakanishi, T. et al. Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortality. J. Clin. Invest. 131, e152386 (2021).
Teruel, M. et al. Integrative epigenomics in Sjogren’s syndrome reveals novel pathways and a strong interaction between the HLA, autoantibodies and the interferon signature. Sci. Rep. 11, 23292 (2021).
Graham, R. R. et al. Genetic variants near TNFAIP3 on 6q23 are associated with systemic lupus erythematosus. Nat. Genet. 40, 1059–1061 (2008).
Musone, S. L. et al. Multiple polymorphisms in the TNFAIP3 region are independently associated with systemic lupus erythematosus. Nat. Genet. 40, 1062–1064 (2008).
Barturen, G. et al. Integrative analysis reveals a molecular stratification of systemic autoimmune diseases. Arthritis Rheumatol. 73, 1073–1085 (2021).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Carnero-Montoro, E., Alarcón-Riquelme, M.E. A basket genetic trial of the vasculitides. Nat Rev Rheumatol 19, 541–542 (2023). https://doi.org/10.1038/s41584-023-00996-4
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41584-023-00996-4
This article is cited by
-
New clinical trial design in precision medicine: discovery, development and direction
Signal Transduction and Targeted Therapy (2024)